Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > EMA Management Board: highlights of March 2025 meeting

https://www.ema.europa.eu/en/news/ema-management-board-highlights-march-2025-meeting

Ryan McArthur 17 March 2025 All news
  • ← New clinical trial map launched in the EU

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • EMA Management Board: highlights of March 2025 meeting
  • New clinical trial map launched in the EU
  • The ANSM’s involvement in the “Joint Actions” of the “EU for Health” program
Copyright © 2018 - Pharmya - Legal terms - Quality Policy